David Abrams
Abrams Capital Management
David Abrams Teva Pharma Industries Ltd ADR stake
total: 84
Abrams Capital Management TEVA trades
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 8
- Held since:
- 2017 Q3
- Held for:
- 26 quarters
- Latest activity:
- 2024 Q1
According to 2026 Q1 report, David Abrams doesn't hold any Teva Pharma Industries Ltd ADR (TEVA) shares. Abrams Capital Management has held TEVA since at least 2013 Q2 with about 2.56M shares in our earliest available record. David Abrams later completely sold out the position and invested in Teva Pharma Industries Ltd ADR again in 2017 Q3. Since at least 2013 Q2, Abrams Capital Management has made 12 more transactions.
When did David Abrams sell Teva Pharma Industries Ltd ADR (TEVA)?
David Abrams sold off the entire Teva Pharma Industries Ltd ADR (TEVA) position in 2024 Q1.
Estimated cost basis*
- Weighted AVG buy price:
- $15.27
- Weighted AVG sell price:
- $10.53
David Abrams's historical trades in Teva Pharma Industries Ltd ADR
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$10.44
|
|
-100% (-5,996,836)
|
-1.95%
|
|
2023 Q4
|
1.95%
|
5,996,836
|
$10.44
|
$62,606,968
|
-24.72% (-1,969,597)
|
-0.68%
|
|
2023 Q1
|
2.23%
|
7,966,433
|
$8.85
|
$70,502,932
|
-50.00% (-7,966,432)
|
-2.51%
|
|
2022 Q4
|
5.18%
|
15,932,865
|
$9.12
|
$145,307,729
|
-33.33% (-7,966,431)
|
-2.09%
|
|
2022 Q3
|
5.56%
|
23,899,296
|
$8.07
|
$192,867,000
|
-0.61% (-147,060)
|
-0.03%
|
|
2019 Q3
|
4.63%
|
$6.88
|
+33.25% (+6,000,000)
|
|||
|
2019 Q1
|
7.95%
|
$15.68
|
-2.57% (-476,016)
|
|||
|
2018 Q4
|
11.80%
|
$15.42
|
-5.12% (-1,000,000)
|
|||
|
2018 Q3
|
11.12%
|
$21.54
|
-1.12% (-220,751)
|
|||
|
2017 Q4
|
12.60%
|
$18.95
|
-8.70% (-1,880,763)
|
|||
|
2017 Q3
|
14.85%
|
$17.60
|
new
|
|||
|
2013 Q3
|
0.00%
|
$39.20
|
-100% (-2,561,269)
|
|||
|
2013 Q2
|
5.81%
|
$39.20
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.